Seungtaek Kim

Institut Pasteur Korea — South Korea

Medicine · Health Sciences

29h-index3.7kcitations119works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(48), Hepatitis C virus research(32), Hepatitis B Virus Studies(23), COVID-19 Clinical Research Studies(22), Liver Disease Diagnosis and Treatment(12)

Publications119 total

Therapeutic potential of an anti-Gn glycoprotein antibody against severe fever with thrombocytopenia syndrome virus infection in A129 mice
Virology·2026
Construction and validation of a cell based reporter assay for identifying inhibitors of SARS coronavirus 2 RNA dependent RNA polymerase activity
Scientific Reports·2025Open Access
Exploring Potential Applications of iPSC-Derived Cell Models for Drug Screening of Specific Diseases
Cytotherapy·2025
High-content Screening to Identify Therapeutic Interventions Against SARS-CoV-2
2025
Assessing student satisfaction with university policies related to in-person classes in the era of COVID-19: a case study from Korea
Scientific Reports·2025· 1 citedOpen Access
Exploring Key Factors of the Future Outlook among Middle-aged: Do Education and Social Values Make a Difference?
Journal of Public Policy Studies·2024
Synthesis and evaluation of N-arylindazole-3-carboxamide derivatives as novel antiviral agents against SARS-CoV-2
Bioorganic & Medicinal Chemistry Letters·2024· 2 citedOpen Access
SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants
International Journal of Molecular Sciences·2024· 4 citedOpen Access
Potential of 6′‑hydroxy justicidin B from Justicia procumbens as a therapeutic agent against coronavirus disease 2019
Phytomedicine·2024· 1 citedOpen Access
Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction
Angewandte Chemie·2024Open Access
Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction
Angewandte Chemie International Edition·2024· 3 citedOpen Access
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
Nature Communications·2024· 10 citedOpen Access
Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic
Science Advances·2024· 2 citedOpen Access
A Randomized Trial of Nafamostat for Covid-19
NEJM Evidence·2023· 12 cited
DeepGT: Deep learning-based quantification of nanosized bioparticles in bright-field micrographs of Gires-Tournois biosensor
Nano Today·2023· 9 citedOpen Access
Erratum to ‘Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in directacting antiviral failure in South Korea’ [Clin Mol Hepatol 2023;29:496-509]
Clinical and Molecular Hepatology·2023Open Access
Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3<i>H</i>)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model
Journal of Medical Virology·2023· 3 citedOpen Access
Protocol for in vitro fluorescence assay of papain-like protease and cell-based immunofluorescence assay of coronavirus infection
STAR Protocols·2023· 3 citedOpen Access
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
2023· 3 citedOpen Access
Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
Clinical and Molecular Hepatology·2023· 3 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Sangeun Jeon(17), Min Seong Jang(9), Hyoung Rae Kim(9), Meehyun Ko(8), Sunoh Kwon(8), Jong Hwan Song(8), Young-Hee Jin(7), Stanley M. Lemon(7), Chul Min Park(7), Kwang‐Hyub Han(7), Jihye Lee(6), Wang‐Shick Ryu(6), Young Sup Shin(6), Jun Young Lee(6), Sang Hoon Ahn(5), Jung Sun Min(4), Tai Young Kim(4), JinAh Lee(4), Do Young Kim(4), MinKyung Yi(3)